Unknown

Dataset Information

0

One-Year All-Cause Mortality and Delivery of the Collaborative Chronic Care Model in General Mental Health Clinics.


ABSTRACT:

Objective

This study aimed to determine whether the evidence-based collaborative chronic care model (CCM) is associated with reduced all-cause mortality among adult patients treated in general mental health clinics.

Methods

Data came from a stepped-wedge, cluster-randomized CCM implementation trial across nine U.S. Department of Veterans Affairs medical centers. Survival analysis was used to estimate the relative effect of the treatment (N=5,570) compared with a control group (N=46,443) over 1 year.

Results

After adjustment for site-level and individual-level acute care utilization factors, analyses indicated that patients treated with the CCM experienced a reduction in all-cause mortality relative to patients in the control cohort (hazard ratio=0.76, 95% CI=0.60-0.95).

Conclusions

This study is the first in which CCM has been shown to reduce all-cause mortality for patients treated in general mental health clinics. Care delivery models should be considered part of efforts to reduce the life expectancy gap between individuals with psychiatric conditions and those without such conditions.

SUBMITTER: Ruderman MA 

PROVIDER: S-EPMC10543562 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

One-Year All-Cause Mortality and Delivery of the Collaborative Chronic Care Model in General Mental Health Clinics.

Ruderman Michael A MA   Byers Amy L AL   Bauer Mark S MS   Stolzmann Kelly K   Miller Christopher J CJ   Connolly Samantha L SL   Kim Bo B  

Psychiatric services (Washington, D.C.) 20230405 10


<h4>Objective</h4>This study aimed to determine whether the evidence-based collaborative chronic care model (CCM) is associated with reduced all-cause mortality among adult patients treated in general mental health clinics.<h4>Methods</h4>Data came from a stepped-wedge, cluster-randomized CCM implementation trial across nine U.S. Department of Veterans Affairs medical centers. Survival analysis was used to estimate the relative effect of the treatment (N=5,570) compared with a control group (N=4  ...[more]

Similar Datasets

2020-05-26 | PXD009325 | Pride
| S-EPMC5661079 | biostudies-literature
| S-EPMC3839971 | biostudies-literature
| S-EPMC3993088 | biostudies-literature
| S-EPMC6159703 | biostudies-literature
| S-EPMC3527503 | biostudies-other
| S-EPMC5562814 | biostudies-other
| S-EPMC8721979 | biostudies-literature
| PRJEB20258 | ENA
| S-EPMC9276626 | biostudies-literature